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Abstract
Ampelocissus africana (Lour) Merr (Vitaceae) is a plant used in traditional medicine in Burkina Faso in the treatment of wounds, 
edema, drops, infections. This study focused on pharmacological investigations effects of methanolic and aqueous extracts from 
Ampelocissus africana (Lour) Merr rhizomes.
The acute toxicity of the extracts from Ampelocissus africana was performed under OECD 423 guidelines. The anti-
inflammatory activity was evaluated in vivo using carrageenan-induced paw edema of mice at the doses to 50, 100, 200, 400, 
600 mg/kg body weight (bw). The antinociceptive activity of the extracts was determined using acetic acid, formalin nociception 
models in mice at the doses to 50, 100, 200, 400 and 600 mg/kg bw. The involvement of ATP-sensitive K+ channel pathway and 
opioid system were tested using glibenclamide, and naloxone respectively at the unique dose (400 mg/kg).
No mortality of mice were observed at dose of 2000 mg/kg b.w. The lethal dose (LD50) value estimated to 5000 mg/kg b.w. 
The tests were showed that the extracts exerted significant dose-dependent anti-inflammatory responses in the paw induced 
by carrageenan (from 37 to 72.90 percent inhibition), antinociceptives in acetic-induced abdominal contractions (from 25.10 to 
63.08%), and in formaldehyde-induced paw licking (from 9.27 to 71.77%) tests. The pretreatment with naloxone and glibenclamide 
did not affect the antinociceptives effects.
The results suggested that the extracts from the rhizomes of Ampelocissus africana possessed anti-inflammatory and antinoci-
ception effects in mice. These effects could justify the uses of this plant in traditional medicine.
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Introduction
Inflammation is considered as a primary physiologic defense
mechanism that helps body to protect itself against external or
internal stimuli. It is a local or systemic tissue reaction that aims
to eliminate the harmful agent, inhibit its further spread and, pos-
sibly, repair damaged tissue. Although this is a defense mecha-
nism, uncontrolled and persistent inflammation can act on com-
plex events and involve to the synthesis of proinflammatory me-
diators such as prostaglandins, leukotrienes and cytokines (TNF
α, IL1β, IL6) [1]. This inflammatory process and pain can then
cause a lot of suffering and discomfort to the victims, lowering
the quality of life and therefore need to be managed [2].
The synthetic chemicals such as non-steroidal anti-
inflammatory drugs (NSAIDs) were widely prescribed all over
the world against inflammatory disorders and pain [3]. How-
ever, currently used anti-inflammatory drugs in prolonged use
are associated with some asymptomatic relief and the greatest
drawback lies in their toxicity to liver, kidney and gastroin-
testinal linings [4]. Therefore, the development of potent anti-
inflammatory drugs with fewer side effects is necessary [5]. The
use herbal medicine is gaining support and recognition across
the world because most of these products are believed to have
bioactive compounds responsible for healing various diseases
without any side effects and at a lower cost. Although, Ampe-
locissus africana (Lour) Merr (Vitaceae) is traditionally used
in the treatment of many types of pain such as drops, rheuma-
tism, edemas, old wounds, circulatory disorders, analgesic and
inflammatory conditions [6].
In Burkina Faso, no scientific report is available to validate
these traditional uses. It is in this context that present study was
designed to evaluate the anti-inflammatory and analgesic activi-
ties as well as acute toxicity of rhizomes extracts of Ampelocis-
sus africana.
Material and methods
Plant collection and sample préparation
The rhizomes of Ampelocissus africana (Lour) Merr were col-
lected in September 2019 around Dedougou, Burkina Faso. The
plant was authenticated at Burkina Faso National Herbarium
(HNBU) within the National center for Scientific and Techno-
logical Research (CNRST) where the voucher specimen (N◦
8754) was deposited.
The rhizomes of the plant were cut into small pieces before
being dried at room temperature away from the sun. The mate-
rial was then reduced to the fine powder and stored in a hermet-
ically freezer bag until use in order to preserve all their physico-
chemical properties.
Chemicals reagents
Ketamine, acetaminophen, acetylsalicylic acid (ASA), gliben-
clamide, naloxone, carrageenan, were purchased from Sigma®
(St Louis, USA). Acetic acid from Prolabo and formol from
Cooper. Tramadol was purchased at a local pharmacy. All sol-
vents used were of analytical grade.
Animals and ethical approval
The NMRI mice weighing 25 ± 5 g (both sexes) were obtained
from the animal’s house of Institute of Health Sciences Re-
search. All the animals were maintained in appropriate cages at
23 ± 2◦C, with 12 hours light / 12 hours dark cycle. The tests
were performed strictly according to the guidelines of labora-
tory animals care and the ethics guidelines for painful experi-
mentation on conscious animals [7]. Animals were fasted for 16
hrs with access to water and weighed before the experiments
(anti-inflammatory and antinociceptives tests). The laboratory
experimentation was carried out according to the experimental
protocols validated by the Institute of Health Sciences Research
laboratories and meeting the international standards in this field
(guidelines established by the European Union on the protection
of animals, CCE Conseil 86/609).
Extraction
• Methanolic extraction: 100 grams of powder was soaked
in 1 liter of methanol during 24 hours. Then, whatman’s filter
paper No.1 was used to filter the mixture. The filtrate was con-
centrated to dryness in vacuum using the rotary evaporator at a
temperature of 40◦C and the concentrate was kept in stove until
the methanol has completely evaporated.
• Aqueous extraction: 100 grams of powder was soaked
in 1 liter of distilled water during 24 hours. After filtration the
mixture was centrifuged at 10 000 trs/min for five minutes and
frozen to be lyophilized. All of these extracts (methanolic and
aqueous) were preserved and used for different tests.
Acute toxicity test
The acute toxicity study was conducted according to the acute
toxic class method of the Organization for Economic Coopera-
tion and Development (OECD, 2001) test guideline 423 [8]. The
female’s mice were randomly into three batches with three mice
/ group. The test was carried out twice After four hours fasting
with access to running water, distilled water at a dose of 10 mL /
kg and the extracts (aqueous and methanolic) at a single dose of
2000 mg/kg of body weight were administered orally by gavage
to the animals. The animals were observed continuously during
two hours after the treatment and next, they were fed. They were
observed daily during 14 days and all signs of toxicity and mor-
tality have been noted. The animals were weighed on the day
of the start of the study, 24 hours, 48 hours, 72 hours after, 7th
day and on the 14thday at the same time. At the end of this test,
the mice were sacrificed and organs such as liver, spleen, kidney,
lung, and heart were collected, observed and weighed.
In vivo anti-inflammatory activity
carrageenan-induced paw edema test The method described
by [9] with minor modifications by [10] was used to carry out
the anti-edematous activity of extracts of Ampelocissus africana.
The edema was induced by injection of 0.05 mL of 1% car-
rageenan (NaCl 0.9%) into the right hind paw of mice. One hour
before the injection of carrageenan, groups of six NMRI mice
were each treated orally either with the extracts (methanolic or
aqueous) at doses of 50, 100, 200, 400, 600 mg/kg bw, either
acetylsalicylic at a dose of 100 mg/kg bw, or distilled water at
10 mL/kg bw. The volume of the right paw was measured 1 hour
before then 1, 3, 5 hours after the injection of carrageenan using
a plethysmometer (Ugo Basile No. 37140).
% Inhibition = [(Ac - At) / Ac] X 100
Ac, At : average difference of the volume increase of the paw
of mice to the control group and treated groups respectively
Analgesic activities
Acetic acid-induced writhing test The analgesic effect of the
extracts was determined by the number of abdominal contortions
induced by the intraperitoneal injection of acetic acid (0.6 %)
according to the method described by [11]. Groups of six mice
each were formed. The mice received either extracts (aqueous or
methanolic) at doses of 50, 100, 200, 400, 600 mg / kg bw, or
distilled water at a dose of 10 mL/kg bw for the white control
batch and acetaminophen at a dose of 200 mg / kg for the ref-
erence batch. 1 hour after oral administration of the substances,
acetic acid was injected into the peritoneum of the mice at a dose
of 10 mL/kg and after five minutes, the number of writhes was
counted in each mouse for 15 minutes. The percentage inhibition
of the number of contortions in mice performed was calculated
against the blank by the formula below:
% Inhibition = [(Wb-Wt) / Wb] × 100
Wb, Wt: Average of the number of writhings of the mice in
the white control batch and the treated batch respectively
Analysis of possible mechanism of action of
Ampelocissus africana: Involvement of ATP-sensitive
K + channels pathway
For the study of the possible contribution of the ATP-sensitive
K + channels of the extracts, the method described by [12] was
used. To do this, the batches of six mice were pretreated orally
with glibenclamide 10 mg/kg bw (an ATP-sensitive K + chan-
nel inhibitor). 15 min after treatment with glibenclamide, the
extracts (aqueous and methanolic) at a dose of 400 mg/kg bw
were administered to the treated group, and the vehicle at 10
mL/kg bw to the white control group. Sixty minutes later, the
animals were assessed using abdominal contortions induced by
acetic acid (0.6%) and after five minutes, the number of contor-
tions was recorded in each mouse for 15 minutes. The percent-
age inhibition of the number of contortions in mice performed
was calculated against the blank by the formula:
% Inhibition = [(Wb-Wt) / Wb] × 100
Wb, Wt: Average of the number of writhings of the mice in
the white control batch and the treated batch respectively
Formalin-induced paw licking test
The antinociceptive activity of the extracts was achieved using
the formalin test described by [13] with slight modifications.
The test batches were treated with the extracts (aqueous and
methanolic) at doses of 100, 200, 400 and 600 mg / kg bw; the
reference batch, was treated with tramadol at 10 mg/kg bw and
the white batch, distilled water at 10 ml/kg orally. The lots con-
sisted of six NMRI mice each. 1 hour after administration, 20 µL
of formalin 2.5% (0.9% NaCl) was injected into the sub plantar
area of the right hind paw. Immediately after the injection of
the formaldehyde solution, the time spent licking or biting the
injected paw was counted for 5 minutes (early phase), then be-
tween 15 and 30 minutes (late phase). The analgesic effect was
determined based on the following formula:
% Inhibition = [(Tb-Tt) / Tb] × 100
Tb, Tt : licking time (in seconds) of the mice in the white
group and the treated group respectively
Analysis of possible mechanism of action of
Ampelocissus africana : Involvement of opioidergic
pathway
The method described by [14] was used to investigate the pos-
sible implication of the opioidergic pathway of Ampelocissus
africana. Groups of six mice each were made up for this anal-
ysis. The test groups were treated with the extracts (aqueous,
methanolic) at 400 mg/kg bw, the white control group received
distilled water at 10 mL/kg bw. Mice were pretreated with nalox-
one 2 mg/kg, (a non-selective opioid receptor antagonist) 15
minutes before administration of the test solutions. 1 hour later,
all mice were subjected to the test of formalin test. Immediately
after the injection of formaldehyde solution, the licking time was
counted for 5 minutes, then between 15-30 minutes and the per-
centage inhibition was determined by the formula:
% Inhibition = [(Tb-Tt) / Tb] × 100
Tb, Tt : licking time (in seconds) of the mice in the white
group and the treated group respectively
Statistical analysis
The data were expressed as Mean± Standard Error of Mean
(SEM). The statistical analysis was carried out using one-way
ANOVA followed by the Bonferroni multiple comparison test on
Graph Pad Prism software version 6.0. The level of significance




The administration of the extracts from Ampelocissus africana at
a single dose of 2000 mg/kg did not show any abnormal behav-
ior during the 2 hours post-treatment. No mortality was noticed 3
days later. The extracts of this plant is classified to the 5th toxic-
ity class with low oral acute toxicity and a LD50 value estimated
to 5000 mg/kg b.w [8, 15].
The weight of the animals recorded on the day of the start of
the test (D0) and one day (D1), 2 days (D2), 3 days (D3), one
week (D7), two weeks (D14) after was presented in the table 1.
The body weight of the animals increased slightly in the treated
batches as in the control. These results suggest that the extracts
did not have a toxic effect on the treated mice. The weight of the
organs of the treated animals is not significantly different com-
pared to the control. Macroscopic analysis of the organs (heart,
spleen, kidneys, lungs, liver) of the mice after 14 days did not
showed any signs of alteration. On the other hand, the adminis-
tration of the extracts did not influence the relative weight of the
vital organs removed at the end of the test (Table 2). The study of
the relative organs weight showed that the extracts had no toxic
effects.
Carrageenan-induced paw edema test
The anti-inflammatory activity of the extracts was estimated at
doses of 50, 100, 200, 400, 600 mg/kg bw against the paw
edema induced by carrageenan. Both extracts significantly re-
duced edema in a dose-dependent manner with a high percent-
age of inhibition of edema observed at the fifth hour (Fig.1a,
Fig.1b) ranging from 69.75 for aqueous extract to 72.90% for
methanolic extract. At the same dose (100 mg / kg), the effect
of the extracts (54.55% for the aqueous extract and 56.95% for
the methanolic extract) was less active than acetylsalicylic acid
(86.18%) used as a reference. The efficient dose (ED50) val-
ues of the methanolic and aqueous extract were respectively 61
mg/kg and 97 mg/kg bw.
The inflammatory response induced by carrageenan is con-
sidered a biphasic model. The early phase of edema that devel-
ops in the paws of mice after injection of carrageenan lasts 90
minutes and is mediated by the release of histamine and sero-
tonin and kinins. The second phase corresponding to the last 5
hours is due to the release of prostaglandins [16, 17]. According
to [18], nitric oxide (NO) is a mediator contributing to the pro-
duction of an inflammatory response in inflammation induced by
carrageenan.
Acetic acid-induced writhing test
The effect of oral administration of extracts using the abdominal
contortion test in mice was shown in Fig. 2. It was found that
both of extracts from A. africana at doses of 50, 100, 200, 400
and 600 mg/kg was able to reduce significant dose-related the
visceral nociceptive effects induced by acetic acid compared to
the control group. The percentage of inhibition was greater than
50% at the dose of 200 mg /kg for the methanolic extract and 200
mg/kg for the aqueous extract. The reference used (paracetamol)
had a percentage inhibition at the dose of 200 mg / kg higher than
the extracts (70.85%). The ED50 values of the methanolic and
aqueous extract of 183 mg/kg and 358 mg/kg bw respectively.
The acetic-induced writhing test is a method used to estimate
peripheral antinociceptive activity [19]. The injection of acetic
in mice would lead to an increase in the level of cyclooxyge-
nase (COX) and products of lipoxygenase (LOX) thus stimulat-
ing the peripheral nociceptive neurons in the peritoneal cavity by
causing pain sensations by the release of various mediators in-
flammatory drugs such as bradykinin, serotonin, histamine, sub-
stance P or prostaglandins (PGE2 and PGF2) [20]. The action
of the extracts could be partly linked to the inhibition of COX
and/or LOX and other inflammatory mediators in peripheral tis-
sues. The nociceptive response elicited by acetic is also depen-
dent on the release of certain cytokines, such as tumor necrosis
factor alpha (TNF-α), interleukin-1 and interleukin-8 by mod-
ulation of macrophages and mast cells located in the peritoneal
cavity [14].
Involvement of ATP-sensitive K+ channels pathway
To assess a possible antinociceptive mechanism including in-
volvement of ATP-sensitive of A. africana extracts, we examined
the effects of pretreatment of glibenclamide (an ATP-sensitive
potassium channel antagonist) in the acetic acid-induced ab-
dominal constriction test. The results in Fig.3 showed that the
administration of glibenclamide (10 mg/kg) alone did not sig-
nificantly affect abdominal contortions assessed by injection of
0.6% acetic acid. The pretreatment with glibenclamide was not
able to reverse the antinociception effect promoted by the ex-
tracts from A. africana, with a dose of 400 mg/kg. This study
Table 1 Mortality and body weight (g) of mice
Extracts Control AAM AA A Control AA M AA A
1st test 2nd test
Mortality (72 H) 0/3 0/3 0/3 0/3 0/3 0/3
Day 0 32.15 ± 0.3 27.28
±
0.9
28.81 ± 0.4 33.68 ± 2.3 24.88 ± 0.4 31.21 ± 0.9
Day 1 32.48 ± 0.5 26.63
±
1.3
28.86 ± 0.4 34.74 ± 1.7 25.63 ± 0.9 31.18 ± 0.7
Day 2 32.67 ± 0.4 27.31
±
1.6
28.33 ± 0.4 35.33 ± 2.4 25.98 ± 1.1 30.67 ± 0.9
Day 3 32.42 ± 0.8 27.66
±
1.5
29.5 ± 0.5 35.17 ± 2.6 25.99 ± 1.2 30.82 ± 0.3
Day 7 31.54 ± 1.2 29.69
±
1.6
28.89 ± 0.3 33.11 ± 1.8 26.93 ± 1.6 29.68 ± 1
Day 14 34.74 ± 0.6 33.18
±
1.08
30.94 ± 0.5 34.59 ± 1.5 28.97 ± 2 32.33 ± 0.3
Mean and standard deviation were presented (n = 3)
AA M: Ampelocissus africana methanolic extract; AA A: Ampelocissus africana aqueous extract
Table 2 Mean relative organs weight (%) of mice
Extracts Control AAM AA A Control AA M AA A
1st test 2nd test
Heart 0.53 ± 0.08 0.52 ± 0.04 0.49 ± 0.01 0.49 ± 0.08 0.47 ± 0.03 0.48 ± 0.03
Spleen 0.5 ± 0.13 0.54 ± 0.18 0.51 ± 0.11 0.41 ± 0.09 0.4 ± 0.04 0.41 ± 0.07
Kidneys 1.15 ± 0.06 1.12 ± 0.08 1.14 ± 0.09 1.06 ± 0.05 1.08 ± 0.06 1.10 ± 0.06
Lung 0.79 ± 0.03 0.82 ± 0.15 0.81 ± 0.12 0.7 ± 0.06 0.68 ± 0.09 0.71 ± 0.09
Liver 5.15 ± 0.19 5.46 ± 0.5 4.85 ± 0.04 4.54 ± 0.14 5.35 ± 0.29 4.68 ± 0.22
Mean and standard deviation were presented (n = 3)
AA M: Ampelocissus africana methanolic extract; AA A: Ampelocissus africana aqueous extract
appeared at the extracts effect (400 mg / kg) and glibenclamide 
(10 mg / kg) treatments.
Reports [21] that glibenclamide specifically blocked the 
ATP-sensitive K+channel, without effects on other types of K+ 
chan-nel such as Ca2+activated K+ channel and voltage-gated 
potas-sium channels. The opening of the K + channel sensitive 
to ATP would be followed by an efflux of K+ions and removal 
excitabil-ity of the cell membrane by hyperpolarization and/or 
repolariza-tion [22].
Formalin-induced paw licking test
The extracts at doses of 100, 200, 400, 600 mg/kg produced a 
dose-dependent inhibition of the licking response induced by 
formalin in both phases: neurogenic phase (0 to 5 min) and in-
flammatory phase (15 at 30 min) compared to the control group 
as shown in Fig. 4. However, the antinociceptive effect was 
more pronounced in the second phase. Tramadol (10 mg/kg) ef-
fectively reduced formalin-induced nociception in both phases 
(1stphase: 70%, 2ndphase: 88.67%). ED50 values of 354 mg/kg
and superior 600 mg/kg bw respectively for the 2nd phase. The
methanolic extract caused a strong inhibition at a dose of 600 mg
/ kg (66.44% for the 1st phase and 71.77% for the 2nd phase.
The formalin model of nociception is described as a method
that discriminates pain in its central and / or peripheral com-
ponents [23]. This model makes it possible to study two types
of pain with an early phase (0-5 min after injection of forma-
lin) corresponding to intense neurogenic pain with the involve-
ment of mediators such as substance P, bradykinin, histamine
and serotonin (evidence of direct stimulation of nociceptors).
The late phase (15-30 min) involves the production and release
of prostaglandins, bradykinin, histamine, serotonin, tachykinins
and glutamate by cells activated by formalin [24].
Involvement of opioidergic pathway
To investigate the possible antinociceptive mechanism on for-
malin test, animals were pretreated with naloxone (2 mg/kg).
Naloxone is a non-selective antagonist at δ, µ, and K opioid re-
ceptors (with an affinity for the µ receptor) which plays a major
Figure 1 Effects of Ampelocissus africana extracts (Fig.1.A and Fig.1.B) on carrageenan-induced edema Values are mean ± S.E.M. n = 6. Data
was analysed using Two-way ANOVA followed by Bonferroni multiple comparison test, ns = no significance P > 0.05, ** = P < 0.01, **** = P <
0.0001 indicate significance compared from control group; (áţą) = P < 0.05, (xx) = P < 0.01, (xxxx) = P < 0.0001 vs reference group (acetylsalicylic
acid)
role in central nociceptive system [25, 26]. For these extracts at
a dose of 400 mg/kg were used. The results showed that the ad-
ministration of naloxone alone did not affect paw licking time.
Together taken, naloxone 15 min before and extracts did not re-
verse the antinociception. Naloxone were not able to reverse the
antinociceptive effect of extracts in mice. This suggests that the
activation of opioid receptors may not be involved in these ef-
fects.
Inflammation is a complex process. It is therefore necessary
to use various models of inflammation, involving the analysis
of several factors, to assess an anti-inflammatory activity of a
substance [27].
These potentialities of A. africana rhizomes could be ex-
ploited in the prevention of diseases with an inflammatory com-
ponent.
Conclusion
All of the results to this study suggest that the rhizomes of
Ampelocissus africana (Lour) Merr rhizomes possesses anti-
inflammatory and antinociceptive properties and can be used
safely orally. That could justify its traditional uses in the treat-
ment of many conditions including diseases with an inflamma-
tory component. These results obtained the scientific basis for
the use of Ampelocissus africana to prevent and treat inflamma-
tory processes.
Figure 2 Effects of Ampelocissus africana extracts on acetic acid-induced abdominal Writhes in mice Each column represents the Mean ± SEM,
n = 6. Data was analysed using One-way ANOVA followed by Bonferroni multiple comparison test,**** = P < 0.0001 indicate significancecompared
from control group; (xx) = P < 0.01, (xxxx) = P< 0.0001 vs reference group (paracetamol)
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Figure 3 Effects of glibenclamide (Gli) on analgesic activity of Ampelocissus africana extracts AA M: Ampelocissus africana methanolic extract;
AA A: Ampelocissus africana aqueous extract
Data are Mean ± SEM, n = 6, analysed using One-wayANOVA followed by Bonferroni multiple comparison test, *** = P < 0.001, ****= P < 0.0001
indicate significance compared from control group, ns = no significance P > 0.05 extract vs pretreatement with Glibenclamide.
Figure 4 Effects of Ampelocissus africana extracts (Fig.4.a and Fig.4.b) in the formalin-induced paw licking test Each column represents the
mean ± S.E.M, n= 6, ***P < 0.001 comparedwith control group, (One-way ANOVA followed by Bonferroni multiple comparisontest), **** = P <
0.0001 indicatesignificance compared from control group, ns = no significance P > 0.05, (xxxx) = P< 0.0001 vs reference group (tramadol)
Figure 5 Effects of Naloxone (Nal) on analgesic activity of Ampelocissus africana extracts AA M: Ampelocissus africana methanolic extract; AA A:
Ampelocissus africana aqueous extract
Data are Mean ± SEM, n = 6, (One-way ANOVA followed by Bonferroni multiple comparison test), **** = P < 0.0001 indicate significance
compared from control group, ns = no significance P > 0.05, (xxxx) = P < 0.0001 extract vs pretreatement with Naloxone.
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